APA (7th ed.) Citation

Alston, A. B., Lin, Z., Gustafson, H. H., Flühmann, B., Digigow, R., Ayala-Nunez, V., & Schmidt, S. (2025). Challenging Traditional ADME Assumptions for Physiologically Based Pharmacokinetic Models for Intravenous Administration of Iron–Carbohydrate Nanomedicines: Potential Utility of Gold Nanoparticle Models as a Roadmap. Clinical Pharmacokinetics, 64(10), 1477. https://doi.org/10.1007/s40262-025-01561-w

Chicago Style (17th ed.) Citation

Alston, Amy Barton, Zhoumeng Lin, Heather Herd Gustafson, Beat Flühmann, Reinaldo Digigow, Vanesa Ayala-Nunez, and Stephan Schmidt. "Challenging Traditional ADME Assumptions for Physiologically Based Pharmacokinetic Models for Intravenous Administration of Iron–Carbohydrate Nanomedicines: Potential Utility of Gold Nanoparticle Models as a Roadmap." Clinical Pharmacokinetics 64, no. 10 (2025): 1477. https://doi.org/10.1007/s40262-025-01561-w.

MLA (9th ed.) Citation

Alston, Amy Barton, et al. "Challenging Traditional ADME Assumptions for Physiologically Based Pharmacokinetic Models for Intravenous Administration of Iron–Carbohydrate Nanomedicines: Potential Utility of Gold Nanoparticle Models as a Roadmap." Clinical Pharmacokinetics, vol. 64, no. 10, 2025, p. 1477, https://doi.org/10.1007/s40262-025-01561-w.